Table 2.
Follow-up campaigns and impact on the administrative vaccination coverage with MMR-1 and MMR-2. Americas 2021–2023.
| Countries with Follow-up Campaigns 2021 | Age group | Vaccine | Target group | Vaccinated children |
Coverage VC
Follow-up |
MMR-1 (%) 2020 | MMR-2 (%) 2020 | MMR-1 (%) 2021 | MMR-2 (%) 2021 | MMR-1 (%) change | MMR-2 (%) change | Use high-quality criteria (Y/N) | Applied micro planning (Y/N) |
| Mexico | 1–9 yo | MR/MMR | 11,662,394 | 11,202,785 | 96 | 100 | 83 | 100 | 97 | 0 | 14 | Yes | Yes |
| Colombia | 1–10 yo | MR/MMR | 7,552,514 | 7,208,981 | 95 | 91 | 88 | 86 | 86 | −5 | −2 | Yes | Yes |
| Bolivia | 1–6 yo | MR/MMR | 1,181,729 | 1,039,922 | 88 | 74 | 46 | 75 | 56 | 1 | 10 | No | No |
| Paraguay | 1–5 yo | MMR | 738,619 | 535,703 | 73 | 68 | 60 | 56 | 51 | −12 | −9 | No | No |
| Total children vaccinated in 2022 | 21,135,256 | 19,987,391 | 95 | ||||||||||
| Countries with Follow up Campaigns in 2022 | Age group | Vaccine | Target group | Vaccinated children |
Coverage VC
Follow-up |
MMR-1 (%) 2021 | MMR-2 (%) 2021 | MMR-1 (%) 2022 | MMR-2 (%) 2022 | MMR-1 (%) change | MMR-2 (%) change | Use high-quality criteria (Y/N) | Applied micro planning (Y/N) |
| Argentina | 13–59 m | MMR | 2,315,692 | 1604631 | 69 | 86 | 79 | 85 | 94 | −1 | 15 | No | No |
| Brazil | 1–4 yo | MR/MMR | 12,927,057 | 6,552,277 | 51 | 73 | 46 | 81 | 58 | 8 | 12 | No | No |
| Dominican Republic | 1–5 yo | MR/MMR | 951,554 | 934,329 | 98 | 88 | 60 | 100 | 87 | 12 | 27 | Yes | Yes |
| El Salvador | 1–6 yo | MMR | 644,089 | 592,562 | 92 | 85 | 70 | 65 | 59 | −20 | −11 | No | No |
| Honduras | 1–6 yo | MMR | 1,669,999 | 1,386,099 | 83 | 81 | 75 | 77 | 71 | −4 | −6 | No | No |
| Nicaragua | 1–6 yo | MMR | 723,790 | 823,127 | 114 | 100 | 96 | 100 | 100 | 4 | 0 | Yes | Yes |
| Venezuela | 1–6 yo | MR/MMR | 2,811,860 | 2,479,675 | 88 | 68 | 38 | N/D | N/D | N/D | N/D | No | No |
| Total children vaccinated in 2022 | 22,044,041 | 14,372,700 | 65 | ||||||||||
| Countries with Follow up in 2023 | Age group | Vaccine | Target group | Goal | Coverage | MMR-1 2022 | MMR-2 2022 | MMR-1 2023 * | MMR-2 2023 * | MMR-1 (%) change | MMR-2 (%) change | Use high-quality criteria (Y/N) | Applied micro planning (Y/N) |
| Ecuador * | 1–12 yo | MR/MMR | 3,189,901 | 3,119,470 | 98 | 74 | 60 | 97 | 81 | 23 | 21 | Yes | Yes |
| Total children vaccinated in 2023 | 3,189,901 | 3,119,470 | 98 | ||||||||||
| Total children targeted and vaccinated | 46,369,198 | 37,479,561 | 81 | ||||||||||
* Preliminary data eJRF. Abbreviations: MR = measles-rubella vaccine; MMR = measles-mumps-rubella vaccine; MMR1 = first MMR dose; MMR2 = second MMR dose; VC = vaccination campaign; yo = years old; m = months. Source: Country reports through the electronic PAHO-WHO/UNICEF Joint Reporting Form (eJRF), 2020–2023 and country reports to the Measles Rubella Elimination Regional Commission. Bold numbers are those percentages ≥ 95% of vaccination coverage.